Journal article
Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction A substudy of the Heart Outcomes Prevention Evaluation (HOPE) trial
Abstract
OBJECTIVES: The purpose of this study was to assess the effects of ramipril on left ventricular mass (LVM) and function in vascular disease patients with controlled blood pressure (BP) and with preserved left ventricular ejection fraction (LVEF).
BACKGROUND: Increased LVM and left ventricular (LV) volume and decreased LVEF predict clinical events. Angiotensin-converting enzyme inhibitors reduce LVM and LV volume and preserve LVEF in patients …
Authors
Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
Journal
Journal of the American College of Cardiology, Vol. 43, No. 12, pp. 2200–2206
Publisher
Elsevier
Publication Date
6 2004
DOI
10.1016/j.jacc.2003.10.073
ISSN
0735-1097
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBlood PressureCanadaCardiovascular DiseasesDiastoleDose-Response Relationship, DrugDouble-Blind MethodEchocardiographyFemaleFollow-Up StudiesHeart VentriclesHumansMaleMiddle AgedPatient ComplianceRamiprilStroke VolumeSystoleTreatment OutcomeVentricular Dysfunction, Left